Detalhe da pesquisa
1.
Metabolic dysfunction-associated steatotic liver disease and atherosclerosis.
Curr Diab Rep
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700793
2.
Type 1 Diabetes Care in Mexico: An Analysis of the RENACED-DT1 National Registry.
Rev Invest Clin
; 73(4): 222-230, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33944861
3.
Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial.
Diabetes Obes Metab
; 22(7): 1083-1093, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052516
4.
VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES: PREVALENCE AND COMORBIDITIES IN 6 COUNTRIES OF LATIN AMERICA (A COHORT OF THE DISCOVER STUDY PROGRAM).
Endocr Pract
; 25(10): 994-1002, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170372
5.
RENACED-DT1: A National Type 1 Diabetes Registry Initiative in Mexico.
Salud Publica Mex
; 62(3): 232-234, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32520478
6.
A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study.
Diabetol Metab Syndr
; 15(1): 258, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38062472
7.
Glycemic Control and Prevention of Diabetic Complications in Low- and Middle-Income Countries: An Expert Opinion.
Diabetes Ther
; 12(5): 1491-1501, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33840067
8.
Glycemic control, treatment and complications in patients with type 1 diabetes amongst healthcare settings in Mexico.
Diabetes Res Clin Pract
; 180: 109038, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487758
9.
[Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)]. / Liraglutida y glimepirida para el control glucémico de la diabetes tipo 2. Análisis de la cohorte mexicana de LEAD-3.
Rev Med Inst Mex Seguro Soc
; 48(5): 543-8, 2010.
Artigo
em Espanhol
| MEDLINE | ID: mdl-21205505
10.
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.
Lancet Diabetes Endocrinol
; 7(8): 596-605, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189519
11.
Safety and efficacy of fimasartan in Mexican patients with grade 1-2 essential hypertension.
Arch Cardiol Mex
; 87(4): 316-325, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209359
12.
Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse ß-cell function in the GetGoal-M and GetGoal-S trials.
J Diabetes Complications
; 30(7): 1385-92, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27267268
13.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.
Diabetes Care
; 39(11): 1972-1980, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650977
14.
Type 1 diabetes care in mexico: an analysis of the renaced-dt1 national registry
Rev. invest. clín
; 73(4): 222-230, Jul.-Aug. 2021. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1347568
15.
Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.
Clin Ther
; 26(5): 680-93, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15220012
16.
Type 2 diabetes mellitus management and body mass index: experiences with initiating insulin detemir in the a1chieve study.
Diabetes Ther
; 5(1): 127-40, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24477670
17.
Predictive and explanatory factors of change in HbA1c in a 24-week observational study of 66,726 people with type 2 diabetes starting insulin analogs.
Diabetes Care
; 37(5): 1237-45, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24595628
18.
Safety and effectiveness of insulin detemir in different age-groups in the a1chieve study.
Diabetes Ther
; 4(1): 77-90, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23670204
19.
The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: results from the A1chieve observational study.
Diabetes Res Clin Pract
; 101(3): 326-32, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24119590
20.
Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972-1980.
Diabetes Care
; 40(6): 809, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428368